Blood Diseases market research reports by DelveInsight

• Renal Anemia – Market Insight, Epidemiology, and Market Forecast – 2034

  Jun 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Renal Anemia – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Renal Anemia – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Renal Anemia, historical and forecasted epidemiology as well as the Renal Anemia market ... Read More

• Thalassemia – Market Insight, Epidemiology, and Market Forecast – 2034

  Jun 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Thalassemia – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Thalassemia – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Thalassemia, historical and forecasted epidemiology as well as the Thalassemia market tre ... Read More

• Acquired hemophilia A – Market Insight, Epidemiology, and Market Forecast – 2034

  Jun 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Acquired hemophilia A – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Acquired hemophilia A – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Acquired hemophilia A, historical and forecasted epidemiology as well ... Read More

• Anemia In Chronic Kidney Disease – Market Insight, Epidemiology, and Market Forecast – 2034

  Jun 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Anemia In Chronic Kidney Disease – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Anemia In Chronic Kidney Disease – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Anemia In Chronic Kidney Disease, historical an ... Read More

• Hemophilia – Market Insight, Epidemiology, and Market Forecast – 2034

  Jun 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Hemophilia – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Hemophilia – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Hemophilia, historical and forecasted epidemiology as well as the Hemophilia market trends ... Read More

• Coagulation Factor Deficiency – Market Insight, Epidemiology, and Market Forecast – 2034

  Jun 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Coagulation Factor Deficiency – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Coagulation Factor Deficiency – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Coagulation Factor Deficiency, historical and forecas ... Read More

• Anemia – Market Insight, Epidemiology, and Market Forecast – 2034

  Jun 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Anemia – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Anemia – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Anemia, historical and forecasted epidemiology as well as the Anemia market trends in the United St ... Read More

• Hemophilia with Inhibitor – Market Insight, Epidemiology, and Market Forecast – 2034

  Jun 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Hemophilia with Inhibitor – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Hemophilia with Inhibitor – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Hemophilia with Inhibitor, historical and forecasted epidemio ... Read More

• Anemia in Elderly – Market Insight, Epidemiology, and Market Forecast – 2034

  Jun 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Anemia in Elderly – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Anemia in Elderly – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Anemia in Elderly, historical and forecasted epidemiology as well as the Anem ... Read More

• Sickle Cell Disease - Epidemiology Forecast - 2034

  Jun 01, 2024  |  Published by: DelveInsight  |  USD 3,950

  Sickle Cell Disease - Epidemiology Forecast - 2034 Key Highlights In 2023, the United States accounted for the highest number of total prevalent cases of SCD trait with approximately 54% cases found in the 6MM. The prevalence of SCD cases was found to be high and rapidly increasing in the 6MM countr ... Read More

• Hemophilia B - Pipeline Insight, 2024

  May 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Hemophilia B - Pipeline Insight, 2024 DelveInsight’s, “Hemophilia B - Pipeline Insight, 2024” report provides comprehensive insights about 15+ companies and 20+ pipeline drugs in Hemophilia Bpipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. ... Read More

• Hemophilia A - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Hemophilia A - Pipeline Insight, 2024 DelveInsight’s, “Hemophilia A - Pipeline Insight, 2024” report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in Hemophilia A pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products ... Read More

• Anemia Associated with Chronic Kidney - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Anemia Associated with Chronic Kidney - Pipeline Insight, 2024 Anemia Associated with Chronic Kidney Overview ""Anemia Associated with Chronic Kidney Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across th ... Read More

• Warm Autoimmune Hemolytic Anemia (WAIHA) - Market Insight, Epidemiology And Market Forecast - 2034

  Mar 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Warm Autoimmune Hemolytic Anemia (WAIHA) - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights The market size of ALS in 2023, in the 7MM was ALS ~ USD 1,000 million. The current standard of care that involves the prescription of riluzole has been effective in slowing the disease ... Read More

• Warm Autoimmune Hemolytic Anemia (WAIHA) - Epidemiology Forecast - 2034

  Mar 01, 2024  |  Published by: DelveInsight  |  USD 3,950

  Warm Autoimmune Hemolytic Anemia (WAIHA) - Epidemiology Forecast - 2034 Key Highlights wAIHA is the most common type of autoimmune hemolytic anemia. People of any age, including children, may develop wAIHA, but it is more common among adults, with a peak incidence between 50 and 70 years. The median ... Read More

• Hemophilia B - Pipeline Insight, 2024

  Feb 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Hemophilia B - Pipeline Insight, 2024 DelveInsight’s, “Hemophilia B - Pipeline Insight, 2024” report provides comprehensive insights about 15+ companies and 20+ pipeline drugs in Hemophilia B pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products ... Read More

• Hemophilia A - Pipeline Insight, 2024

  Feb 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Hemophilia A - Pipeline Insight, 2024 DelveInsight’s, “Hemophilia A - Pipeline Insight, 2024” report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in Hemophilia A pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products ... Read More

• Hemophilia A - Market Insight, Epidemiology And Market Forecast - 2034

  Feb 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Hemophilia A - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights Usher Syndrome (USH) is the most common genetic condition responsible for combined loss of hearing and vision. Balance disorders and bilateral vestibular areflexia are also observed in some cases. Limited knowledge ... Read More

• Aplastic Anemia - Market Insight, Epidemiology And Market Forecast - 2034

  Feb 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Aplastic Anemia - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights In the 7MM, United States accounted for the largest market size in 2023, with approximately USD ~190 million. Aplastic anemia is a rare and severe nonmalignant disease characterized by autoimmune destruction of ... Read More

• Hemoglobinopathies- Market Insights, Competitive Landscape, and Market Forecast - 2027

  Apr 01, 2023  |  Published by: DelveInsight  |  USD 2,750

  Hemoglobinopathies- Market Insights, Competitive Landscape, and Market Forecast - 2027 Hemoglobinopathies Market By Indication (Thalassemia, Sickle Cell Anaemia, And Others), By Treatment (Stem Cell Therapy, Blood Transfusion, Iron Chelation Therapy, And Others), and by geography is expected to adva ... Read More

• Fanconi Anemia - Pipeline Insight, 2022

  Nov 01, 2022  |  Published by: DelveInsight  |  USD 1,250

  Fanconi Anemia - Pipeline Insight, 2022 DelveInsight’s, “Fanconi Anemia - Pipeline Insight, 2022,” report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in Fanconi Anemia pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage prod ... Read More

• Thrombocytopenia - Market Insight, Epidemiology And Market Forecast - 2032

  Sep 01, 2022  |  Published by: DelveInsight  |  USD 7,500

  Thrombocytopenia - Market Insight, Epidemiology And Market Forecast - 2032 DelveInsight’s ‘Thrombocytopenia - Market Insights, Epidemiology, and Market Forecast–2032’ report delivers an in-depth understanding of Thrombocytopenia historical and forecasted epidemiology as well as the Thrombocytopenia ... Read More

• Hemophilia- Pipeline Insight, 2022

  Jul 01, 2022  |  Published by: DelveInsight  |  USD 3,000

  Hemophilia- Pipeline Insight, 2022 DelveInsight’s, “Hemophilia- Pipeline Insight, 2022,” report provides comprehensive insights about 80+ companies and 80+ pipeline drugs in Hemophilia pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It als ... Read More

• Chemotherapy Induced Anemia - Pipeline Insight, 2022

  Mar 01, 2022  |  Published by: DelveInsight  |  USD 1,250

  DelveInsight’s, “ Chemotherapy Induced Anemia- Pipeline Insight, 2022 ,” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Chemotherapy Induced Anemia pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also ... Read More

• Chemotherapy Induced Anemia - Market Insight, Epidemiology And Market Forecast - 2032

  Feb 01, 2022  |  Published by: DelveInsight  |  USD 7,500

  DelveInsight’s " Chemotherapy-induced anemia – Market Insights, Epidemiology, and Market Forecast – 2032 " report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the market trends of chemotherapy-induced anemia in the United States, EU5 (Germany, Spain, It ... Read More

< prev 1 2 3 next >